Susquehanna International Group, LLP Compugen LTD Put Options Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 15, 2024
BUY
$1.68 - $2.52 $99,456 - $149,184
59,200 Added 102.96%
116,700 $196,000
Q1 2024

May 07, 2024
BUY
$1.75 - $2.95 $63,175 - $106,495
36,100 Added 168.69%
57,500 $148,000
Q4 2023

Feb 14, 2024
BUY
$0.53 - $2.0 $11,342 - $42,800
21,400 New
21,400 $42,000
Q3 2022

Nov 14, 2022
SELL
$0.66 - $2.32 $8,580 - $30,159
-13,000 Reduced 49.43%
13,300 $9,000

Others Institutions Holding CGEN

# of Institutions
73
Shares Held
13.3M
Call Options Held
191K
Put Options Held
135K
View Full List

About COMPUGEN LTD

CGEN Quotes by TradingView
  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $142M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email